Tumor Metabolome Targeting and Drug Development
In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism.

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate. However, the metabolism of malignant cells generally varies from that of normal cells. These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mihondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect—these topics and more are discussed in this volume.

1133098783
Tumor Metabolome Targeting and Drug Development
In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism.

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate. However, the metabolism of malignant cells generally varies from that of normal cells. These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mihondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect—these topics and more are discussed in this volume.

169.99 In Stock
Tumor Metabolome Targeting and Drug Development

Tumor Metabolome Targeting and Drug Development

Tumor Metabolome Targeting and Drug Development

Tumor Metabolome Targeting and Drug Development

Hardcover(2014)

$169.99 
  • SHIP THIS ITEM
    In stock. Ships in 1-2 days.
  • PICK UP IN STORE

    Your local store may have stock of this item.

Related collections and offers


Overview

In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism.

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate. However, the metabolism of malignant cells generally varies from that of normal cells. These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mihondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect—these topics and more are discussed in this volume.


Product Details

ISBN-13: 9781461495444
Publisher: Springer New York
Publication date: 01/09/2014
Series: Cancer Drug Discovery and Development
Edition description: 2014
Pages: 198
Product dimensions: 6.20(w) x 9.20(h) x 0.70(d)

About the Author

Dr. Steven B. Kanner is the Vice President of Discovery Biology at Astex Pharmaceuticals. He has been a pharmaceutical research leader with over 20 years of extensive experience in novel target identification and validation, assay development, both small molecule and antibody drug discovery, and expertise in oncology, immunology and inflammation. For more detail, please see the attached CV herewith.

Table of Contents

Tumor cell metabolic reprogramming and drug targeting.- Cancer metabolism: a nexus of matter, energy and reactive oxygen species.- Regulating mihondrial respiration in cancer.- Regulation of cancer cell metabolism by hypoxia.- Glucose metabolism and the anti-oxidative defence system in cancer cells: Options for application of ROS-based anticancer drugs.- Modulating autophagy and the “reverse Warburg effect”.- Metabolic adaptation in reprogrammed cancer cells.- Index.
From the B&N Reads Blog

Customer Reviews